Glen Clova Scientific (GCS) is disrupting biologic therapeutic treatment pathways with its unique VLP platform that delivers powerful and accessible therapeutics.

With its proprietary virus-like particle (VLP) platform delivering targeted immune modulation, the company is delivering a disruptive alternative to monoclonal antibodies – with lower and faster development cost. The GCS platform is widely applicable for development of vaccines, oncology therapeutics, infectious disease therapeutics and in immune-inflammatory disease.

Glen Clova Scientific

Org chart

Teams

Offices

Glen Clova Scientific

Org chart

Teams

Offices

Related companies